Estimating eligibility for lung cancer screening in an Australian cohort, including the effect of spirometry

Medical Journal of Australia

Volumn 204, Issue 11, 2016, Pages 406.e1-406.e6

  Manners, David ^a   Hui, Jennie ^b,c   Hunter, Michael ^b,c   James, Alan ^a,c   Knuiman, Matthew W ^c   McWilliams, Annette ^d   Mulrennan, Siobhain ^a,b   Musk, Arthur W Bill ^a,b   Brims, Fraser J H ^a,c  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b Busselton Population Medical Research Foundation   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d FIONA STANLEY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SALBUTAMOL;

ADULT; AGE; AGED; ARTICLE; BODY MASS; BRONCHODILATATION; CANCER RISK; CANCER SCREENING; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENDER; HUMAN; INHALATION SPACER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MIDDLE AGED; SMOKING; SPIROMETRY; AUSTRALIA; EARLY CANCER DIAGNOSIS; LUNG TUMOR; MASS SCREENING; ORGANIZATION AND MANAGEMENT; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA;

AGED; AUSTRALIA; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; ELIGIBILITY DETERMINATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; RISK ASSESSMENT; SMOKING; SPIROMETRY;

EID: 84975109858     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja16.00043     Document Type: Article

References (27)

1. Australian Institute of Health and Welfare, Cancer Australia. Lung cancer in Australia: an overview (Cat. No. CAN 58; Cancer Series No. 64). Canberra: AIHW, 2011. http://www.aihw.gov.au/ WorkArea/DownloadAsset.aspx?id=1 0737421095&libID=10737421094 (accessed Feb 2016).
2. Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365: 395-409.
3. Moyer VA. Screening for lung cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2014; 160: 330-338.
4. Kovalchik SA, Tammemägi M, Berg CD, et al. Targeting of low-dose CT screening according to the risk of lungcancer death. N Engl J Med 2013; 369: 245-254.
5. Black WC, Gareen IF, Soneji SS, et al. Cost-effectiveness of CT screening in the national lung screening trial. N Engl J Med 2014; 371: 1793-1802.
6. Field JK, Duffy SW, Baldwin DR, et al. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax 2015; 71: 161-170.
7. Kauczor HU, Bonomo L, Gaga M, et al. ESR/ERS white paper on lung cancer screening. Eur Radiol 2015; 25: 2519-2531.
8. Tammemägi MC, Katki HA, Hocking WG, et al. Selection criteria for lungcancer screening. N Engl J Med 2013; 368: 728-736.
9. Tammemägi MC, Church TR, Hocking WG, et al. Evaluation of the lung cancer risks at which to screen ever-and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med 2014; 11: e1001764.
10. Toelle BG, Xuan W, Bird TE, et al. Respiratory symptoms and illness in older Australians: the Burden of Obstructive Lung Disease (BOLD) study. Med J Aust 2013; 198: 144-148. https://www.mja.com.au/journal/2 013/198/3/respiratory-symptoms-andillness-older-australians-burdenobstructive-lung
11. Tammemägi MC, Lam SC, McWilliams AM, et al. Incremental value of pulmonary function and sputum DNA image cytometry in lung cancer risk prediction. Cancer Prev Res (Phila) 2011; 4: 552-561.
12. Young RP, Duan F, Chiles C, et al. Airflow limitation and histology shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy. Am J Respir Crit Care Med 2015; 192: 1060-1067.
13. Australian Bureau of Statistics. 4364.0. 55.001. Australian Health Survey: first results, 2011e12. Canberra: ABS, 2012. http://www.abs.gov.au/AUSSTATS/ abs@.nsf/Lookup/4364.0.55.001 MainþFeatures12011-12? OpenDocument (accessed Feb 2016).
14. James A, Hunter M, Straker L, et al. Rationale, design and methods for a community-based study of clustering and cumulative effects of chronic disease processes and their effects on ageing: the Busselton healthy ageing study. BMC Public Health 2013; 13: 936.
15. Brims F, McWilliams A, Fong K. Lung cancer screening in Australia: progress or procrastination? Med J Aust 2016; 204: 4-5. https://www.mja.com.au/ journal/2016/204/1/lung-cancerscreening-australia-progress-orprocrastination
16. Brims FJ, Murray CP, de Klerk N, et al. Ultra-low-dose chest computer tomography screening of an asbestosexposed population in Western Australia. Am J Respir Crit Care Med 2015; 191: 113-116.
17. Marshall HM, Bowman RV, Ayres J, et al. Lung cancer screening feasibility in Australia. Eur Respir J 2015; 45: 1734-1737.
18. Department of Health, Standing Committee on Screening. Position statement. Lung cancer screening using low-dose computed tomography. 2015. http://www.cancerscreening.gov.au/ internet/screening/publishing.nsf/ Content/lung-cancer-screening (accessed Feb 2016).
19. Fiscella K, Winters P, Farah S, et al. Do lung cancer eligibility criteria align with risk among Blacks and Hispanics? PLoS One 2015; 10: e0143789.
20. Howard DH, Richards TB, Bach PB, et al. Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening. Cancer 2015; 121: 4341-4347.
21. Ma J, Ward EM, Smith R, et al. Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer 2013; 119: 1381-1385.
22. Tammemägi MC, Pinsky PF, Caporaso NE, et al. Lung cancer risk prediction: prostate, lung, colorectal and ovarian cancer screening trial models and validation. J Natl Cancer Inst 2011; 103: 1058-1068.
23. Oken MM, Hocking WG, Kvale PA, et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Trial. JAMA 2011; 306: 1865-1873.
24. Scollo M, Winstanley MH. Tobacco in Australia: facts and issues. Fourth edition. Melbourne: Cancer Council Victoria, 2012. http://www. tobaccoinaustralia.org.au (accessed Feb 2016).
25. Australian Population Health Development Principal Committee, Screening Subcommittee. Population based screening framework. Canberra: Australian Health Ministers' Council, 2008. http://www.cancerscreening.gov. au/internet/screening/publishing.nsf/ Content/16AE0B0524753EE9CA257 CEE0000B5D7/$File/Populationbased-screening-framework.PDF (accessed Feb 2016).
26. Pastorino U, Boffi R, Machianò A, et al. Stopping smoking reduces mortality in low-dose computed tomography (LDCT) screening volunteers. J Thorac Oncol 2016; doi: http://dx.doi.org/ 10.1016/j.jtho.2016.02.011 [Epub ahead of print].
27. Field JK, Devaraj A, Duffy SW, et al. CT screening for lung cancer: Is the evidence strong enough? Lung Cancer 2016; 91: 29-35.